For Doctors & Clinicians
A transparent, evidence-based referral pathway for men presenting with symptoms of androgen deficiency.
Why we founded MYTRT
Founded in clinic, built for men
MYTRT was founded by a small group of doctors with backgrounds in the NHS and private practice. Across our clinical work, we repeatedly encountered men describing the same difficulties: persistent fatigue, low mood, poor sleep, reduced libido, declining strength and motivation, and a growing sense that they no longer felt like themselves.
For many of these men, accessing a comprehensive assessment that considered the full picture proved difficult. Some faced long waiting lists. Others felt that their symptoms had been dismissed because a single testosterone result fell just inside a laboratory reference range.
These experiences reflect a much wider issue. Symptomatic testosterone deficiency is estimated to affect approximately 40% of men aged over 45 [1], with prevalence increasing with age and in men with conditions such as obesity and type 2 diabetes.
There is also growing evidence of a generational decline in male testosterone levels that cannot be explained by ageing alone. A major analysis presented in 2026, involving more than 118,000 men across five countries, reported that average total testosterone levels declined by approximately 54% between 1972 and 2019 [2]. Earlier longitudinal studies have reported reductions of approximately 25–33% over periods of 17–20 years [3]. The causes are likely to be complex and may include rising rates of obesity, metabolic disease, poor sleep, physical inactivity, chronic stress and environmental exposures.
We created MYTRT to help close this gap.
MYTRT is a doctor-led clinic, not simply a prescription service. Every blood result is clinically reviewed by a doctor, and every recommendation considers the patient’s symptoms, medical history, repeat blood results and wider health. Patients have direct access to ongoing clinical support throughout their care. Where medication is appropriate, prescribing and final dosing are undertaken by our expert doctors with treatment supplied through our regulated pharmacy partner.
Being doctor-led also means being honest about who TRT is and is not appropriate for.
A diagnosis of testosterone deficiency requires compatible symptoms together with consistently low testosterone levels, confirmed through appropriate repeat morning blood testing. We will never recommend TRT based on symptoms alone, a single blood result or the pursuit of an arbitrary idea of being “optimal”.
Our objective is to restore testosterone to a healthy physiological range where there is a clear clinical indication [4], while monitoring each patient carefully and adjusting treatment according to their individual response.
We also believe that men who do not meet the criteria for TRT should not simply be turned away. We treat the patient, not the numbers.
A man may have low testosterone levels without the symptoms required for a clinical diagnosis. Equally, he may experience significant symptoms despite testosterone levels that are not clinically low. In either situation, further investigation may be needed.
That is why our pathway extends beyond testosterone treatment. Through our trusted clinical partner, messageGP, a CQC-registered online GP service, we can facilitate a private GP consultation so that other possible causes, including thyroid disease, anaemia, sleep disorders, medication effects, mental health conditions and metabolic illness, can be properly considered and investigated.
Our goal is simple: to help men understand what is happening to their health, provide safe and evidence-based treatment where appropriate, and ensure that no man is left without a clear path forward.
Our medical team
Doctor-led, at every stage
Medical Director
GMC No. 7404207
Director of Strategy
GMC No. 7554238
GP and Registered Manager
GMC No. 7082769
GP and Health Data Scientist
GMC No. 7492303All MYTRT doctors are registered with the General Medical Council.
Clinical protocol
Evidence-based management
We are a doctor-led clinic, not a prescription service. Every result is reviewed by a doctor, every clinical recommendation is made by a doctor, and every patient has direct access to clinical support throughout their care. Where medication is appropriate, prescribing and final dosing are undertaken by our expert doctors, with treatment supplied through our regulated pharmacy partner.
A diagnosis of clinically low testosterone requires both symptoms and confirmed low blood results, and treatment will never be recommended on the basis of one without the other.
If a patient’s blood work shows low testosterone without symptoms, or they have real symptoms but their testosterone is not clinically low, something still deserves investigation. Through our sister company messageGP, a CQC-regulated online GP service, we can facilitate a private GP appointment so the underlying cause is properly explored.
Clinical governance
Regulated pathway
MYTRT is operated by Elevate Healthcare Group Limited in partnership with Messagegp Limited. GP services and all regulated activities are provided entirely by our CQC-registered partner company, Messagegp Ltd.
Smartway Pharma (SmartRx)
GPhCPharmacy partner – treatment supply and safety checks
Premises No. 9010774
Clinilabs
CQC & UKASDiagnostic screening partner & blood testing laboratory
UKAS Lab No. 27641 · ISO 15189:2022 · CQC 1-12815843796
Messagegp Ltd (messageGP)
CQCGP services and regulated activities (sister company)
Provider No. 1-17195141915
References
- Mulligan T, et al. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract. 2006;60(7):762–769. View
- Levine H, et al. Secular decline in testosterone levels: meta-analysis presented at ESHRE 2026. Data from 118,593 men across Israel, US, Brazil, Finland and Denmark, 1972–2019.
- Travison TG, et al. A population-level decline in serum testosterone levels in American men. J Clin Endocrinol Metab. 2007;92(1):196–202.
- Hackett G, et al. The British Society for Sexual Medicine Guidelines on Male Adult Testosterone Deficiency, with Statements for Practice. World J Mens Health. 2023;41(3):508–537. View
Refer a patient for a free consultation
If you are seeing a man with symptoms of androgen deficiency who is struggling to access assessment, we are happy to help. The initial consultation with our medical team is free, and if TRT is not clinically right for him, we will say so and route him back to appropriate care.